Literature DB >> 25210678

Marginal zone mucosa associated lymphoid tissue diffuse large B cell lymphoma.

Adrian Pedro Noriega Aldave1, Shikha Jaiswal1, Stephen L Davidson1.   

Abstract

CONTEXT: Non-Hodgkin's lymphomas (NHL) primarily involving the orbit, is relatively uncommon. Rarely two pathologically different NHL cell types have been found to be coexistent. CASE REPORT: We report a case of orbital lymphoma in a 62-year-old male with rare histopathological findings secondary to transformation of once cell type into another. Tissue diagnosis and molecular studies led to revelation of diffuse large B cell lymphoma evolving from MALT lymphoma.
CONCLUSION: Proliferation of two morphologically and phenotypically different B cells resulting in malignancy has not been found in the orbit so far. They are usually aggressive tumors and require chemo-immunotherapy.

Entities:  

Keywords:  Diffuse large B cell lymphoma; Marginal zone mucosa-associated lymphoid tissue lymphoma; Orbital lymphoma; Rituximab

Year:  2014        PMID: 25210678      PMCID: PMC4158653          DOI: 10.4103/1947-2714.139307

Source DB:  PubMed          Journal:  N Am J Med Sci        ISSN: 1947-2714


  10 in total

1.  Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma.

Authors:  A H Meyer; A Stroux; K Lerch; J Eucker; J Eitle; K Hohloch; M Andrzejak; K Possinger; B Dörken; A Pezzutto; C W Scholz
Journal:  Ann Oncol       Date:  2014-01       Impact factor: 32.976

2.  Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.

Authors:  Andrés J M Ferreri; Silvia Govi; Annalisa Colucci; Roberto Crocchiolo; Giulio Modorati
Journal:  Ophthalmology       Date:  2010-08-14       Impact factor: 12.079

Review 3.  Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.

Authors:  Chris M Bacon; Ming-Qing Du; Ahmet Dogan
Journal:  J Clin Pathol       Date:  2006-09-01       Impact factor: 3.411

Review 4.  Primary lymphoma of the ocular adnexa (orbital lymphoma) and primary intraocular lymphoma.

Authors:  D K Woolf; M Ahmed; P N Plowman
Journal:  Clin Oncol (R Coll Radiol)       Date:  2012-04-20       Impact factor: 4.126

Review 5.  Transformation of indolent mantle cell lymphoma to pleomorphic mantle cell lymphoma: case report and review of clinical and morphologic variants.

Authors:  Mark J Kiel; Lauren B Smith
Journal:  Arch Pathol Lab Med       Date:  2012-08       Impact factor: 5.534

Review 6.  Diffuse large B-cell lymphoma of the uterus suspected of having transformed from a marginal zone B-cell lymphoma harboring trisomy 18: a case report and review of the literature.

Authors:  Kei-Ji Sugimoto; Hidenori Imai; Asami Shimada; Mutsumi Wakabayashi; Yasunobu Sekiguchi; Noriko Nakamura; Tomohiro Sawada; Hiroshi Izumi; Yasunori Ota; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

7.  Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases.

Authors:  Hakan Demirci; Carol L Shields; Ekaterine C Karatza; Jerry A Shields
Journal:  Ophthalmology       Date:  2008-04-28       Impact factor: 12.079

8.  Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005.

Authors:  Lene D Sjö; Elisabeth Ralfkiaer; Jan U Prause; Jorgen H Petersen; Jakob Madsen; Niels T Pedersen; Steffen Heegaard
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-04       Impact factor: 4.799

9.  Orbital lymphoma: imaging features and differential diagnosis.

Authors:  Gema Priego; Carles Majos; Fina Climent; Amadeo Muntane
Journal:  Insights Imaging       Date:  2012-04-18

10.  Orbital lymphoma: diagnostic approach and treatment outcome.

Authors:  André M Eckardt; Juliana Lemound; Majeed Rana; Nils-Claudius Gellrich
Journal:  World J Surg Oncol       Date:  2013-03-18       Impact factor: 2.754

  10 in total
  1 in total

1.  Characteristics of orbital lymphoma: a clinicopathological study of 26 cases.

Authors:  Daniel Briscoe; Christine Safieh; Yokrat Ton; Hava Shapiro; Ehud I Assia; Dvora Kidron
Journal:  Int Ophthalmol       Date:  2017-03-31       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.